Close
  Indian J Med Microbiol
 

Figure 3: A 29-year-old man with poorly differentiated neuroendocrine tumor (Ki-67 = 28%).99mTc-octreotide scintigraphy and post-177Lu-DOTATATE therapy images showed intense uptake within the skeletal lesions, predicting a good response to177Lu-DOTATATE therapy in patients with somatostatin-expressing neuroendocrine tumors. However,18F-fluorodeoxyglucose positron emission tomography-computed tomography images demonstrated numerous18F-fluorodeoxyglucose-avid lesions throughout the skeleton and marrow, representing a poor prognosis

Figure  3: A 29-year-old man with poorly differentiated neuroendocrine tumor (Ki-67 = 28%).<sup>99m</sup>Tc-octreotide scintigraphy and post-<sup>177</sup>Lu-DOTATATE therapy images showed intense uptake within the skeletal lesions, predicting a good response to<sup>177</sup>Lu-DOTATATE therapy in patients with somatostatin-expressing neuroendocrine tumors. However,<sup>18</sup>F-fluorodeoxyglucose positron emission tomography-computed tomography images demonstrated numerous<sup>18</sup>F-fluorodeoxyglucose-avid lesions throughout the skeleton and marrow, representing a poor prognosis